EUCTR2017-004348-39-FR进行中（未招募）1 期
Association between methotrexate erythrocyte polyglutamate concentration and clinical response in rheumatoid arthritis patients treated with subcutaneous injectable methotrexate - POLYG
CHU Saint-Etienne0 个研究点目标入组 60 人开始时间: 2018年1月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •RA patients in remission (DAS 28<2.6) with MTX treatment for at least 6months, and with a stable dose for 3months.
- •And patients with a High Disease Activity Rheumatoid Arthritis activity (DAS 28>3.2) with MTX treatment (= 15 mg/semaine), taking MTX treatment for at least 6months with a stable subcutaneous weekly MTX injection (= 15 mg/semaine) treatment during the previous 3 months.
- •Patients followed in the Rheumatology Department at the CHU de St Etienne.
- •Social security affiliation.
- •Signed informed consent.
- •Age > 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Patients treated with another csDMARD.
- •Another diagnostic than RA.
研究者
相似试验
进行中（未招募）
1 期
Association between metabolits of methotrexate and clinical response in rheumatoid arthritis patientsMedDRA version: 21.0Level: LLTClassification code 10042952Term: Systemic rheumatoid arthritisSystem Organ Class: 100000004859rheumatoid arthritisEUCTR2019-003700-12-FRCHU Saint-Etienne60
终止
4 期
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological DrugRheumatoid ArthritisNCT04470453Centre Hospitalier Universitaire de Saint Etienne16
已完成
4 期
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable MethotrexateRheumatoid ArthritisNCT03445871Centre Hospitalier Universitaire de Saint Etienne60
已完成
4 期
Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid ArthritisRheumatoid ArthritisNCT00695188Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation19
已完成
不适用
The relationship between methotrexate drug and blood pressure in patients with rheumatoid arthritisBlood pressureArterial functionInflammatory and Immune System - Rheumatoid arthritisCardiovascular - HypertensionCardiovascular - Other cardiovascular diseasesRheumatoid ArthritisACTRN12616001366448Flinders University114